Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1962 1
1963 10
1964 9
1965 1
1966 1
1967 1
1968 1
1969 2
1971 1
1972 2
1973 1
1974 1
1975 1
1976 1
1977 3
1978 5
1979 2
1980 5
1981 3
1982 2
1983 3
1984 3
1985 2
1986 5
1987 1
1988 7
1989 5
1990 4
1991 6
1992 5
1993 8
1994 7
1995 12
1996 9
1997 12
1998 13
1999 22
2000 16
2001 17
2002 21
2003 25
2004 19
2005 23
2006 22
2007 28
2008 47
2009 29
2010 39
2011 47
2012 39
2013 36
2014 34
2015 45
2016 35
2017 34
2018 36
2019 33
2020 50
2021 42
2022 42
2023 49
2024 46
2025 38
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

993 results

Results by year

Filters applied: . Clear all
Page 1
Multiomic profiling of responses to clinical and novel bisphosphonates reveals extraskeletal effects on ageing related signatures.
Lu J, Rao SR, Knowles H, Zhan H, Gamez B, Qin M, Platt E, Frost LR, Allen TJ, Marshall G, Huber KVM, Bauer LG, Vendrell I, O'Brien DP, Kessler B, Horne A, Reid IR, Bountra C, Kirkland JL, Khosla S, Ebetino FH, Roldan E, Russell RGG, Edwards JR. Lu J, et al. Among authors: khosla s. Signal Transduct Target Ther. 2026 Jul 15;11(1):277. doi: 10.1038/s41392-026-02799-x. Signal Transduct Target Ther. 2026. PMID: 42448670 Free PMC article.
Plasma proteomics reveals divergent sex-specific senescence and bone biology signatures across neurodegenerative diseases.
Kaipa S, Zhai T, Meka SRK, Moran-Losada P, He Z, Channappa D, Se-Hwee Oh H, Rutledge J, Zeineh M, Agudelo A, Nair R, Wilson EN, Bandela M, Raghuraman K, Al-Rajhi A, Akkiraju A, Hwang J, Longo FM, Ramirez V, Poston K, Neretti N, Khosla S, Snyder MP, Wyss-Coray T, Henderson VW, Suryadevara V. Kaipa S, et al. Among authors: khosla s. bioRxiv [Preprint]. 2026 May 27:2026.05.23.727339. doi: 10.64898/2026.05.23.727339. bioRxiv. 2026. PMID: 42244657 Free PMC article. Preprint.
Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.
Levy N, Sheridan P, Campbell U, Lenis D, O'Doherty I, Estrin A, Gautam N, Iyer M, McDonald S, Belli A, Carrigan G, Chan KA, Chen J, Chia V, Dhopeshwarkar N, Eckert J, Fernandes L, Greshock J, Hendricks-Sturrup R, Huang J, Jiao X, Khosla S, Lunacsek O, McRoy L, Natanzon Y, Ovbiosa O, Pace N, Pinheiro S, Rees M, Rider J, Rimawi MF, Robinson T, Rodriguez-Watson C, Sangli C, Sarsour K, Schneeweiss S, Shapiro M, Stewart M, Taylor A, Wang CK, Wang S, Zhang Y, Madsen A. Levy N, et al. Among authors: khosla s. Clin Pharmacol Ther. 2026 Aug;120(2):440-451. doi: 10.1002/cpt.70310. Epub 2026 Jun 4. Clin Pharmacol Ther. 2026. PMID: 42240135 Free PMC article.
Transcription-independent induction of rapid-onset senescence is integral to healing.
Valdivieso K, Rozmaric T, Victorelli S, Jadhav V, Ring NAR, Machcińska-Zielińska S, Schädl B, Dworak H, Klinaki E, Fischer I, Gadecka A, Moskalevska I, Kostrebic S, Kienberger M, Marzec E, Efraimoglou C, Zanchetta A, Cherfils-Vicini J, Lushchak O, Löscher A, Kolbe T, Dahlhoff M, Pirius NE, Gutasi A, Takacs S, Ferguson J, Podesser BK, Slezak P, Monroe D, Zhou B, Khosla S, Grillari J, Redl H, Jurk D, Ogrodnik M. Valdivieso K, et al. Among authors: khosla s. Nat Cell Biol. 2026 Jun;28(6):1281-1299. doi: 10.1038/s41556-026-01948-2. Epub 2026 May 28. Nat Cell Biol. 2026. PMID: 42209725 Free PMC article.
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.
Keddar MR, Carrasco Pro S, Rabbie R, Kalender Atak Z, Muyas F, Stewart AC, Hammond SA, Palmer DC, Stewart R, Carey M, Burke K, Sidders B, Davies J, Dry JR, Martincorena I, Khosla S, Schoenfeld A, Miller ML. Keddar MR, et al. Among authors: khosla s. J Immunother Cancer. 2026 May 19;14(5):e014321. doi: 10.1136/jitc-2025-014321. J Immunother Cancer. 2026. PMID: 42156138 Free PMC article.
993 results